The Kyasanur Forest Disease Vaccine (KFDV) isolate will be used in R&D activities by experienced vaccine manufacturers, pharmaceutical corporations, and research and development organisations for the development of a vaccine against KFD and its manufacture or commercialization. In order to…
Altuviiio [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], formerly known as efanesoctocog alfa, is a first-in-class, highly sustained factor VIII replacement therapy that has received FDA approval. For both adults and children with haemophilia A, the use of altuviiio is recommended…
M1 MedDRA Terminology M1: MedDRA- Medical Dictionary for Regulatory Activities M1: PtC WG MedDRA Points to Consider M2 Electronic Standards M2: EWG Electronic Standards for the Transfer of Regulatory Information M3 Nonclinical Safety Studies M3(R2): Guidance on Nonclinical Safety Studies…
Model Paper-1 Model Paper-2 Model Paper-3 Model Paper-4 Model Paper-5
E1: Clinical Safety for Drugs used in Long Term Treatment E1: The Extent Of Population Exposure To Assess Clinical Safety for Drugs intended for long term treatment of non-life threatening conditions. E2A-E2F: Pharmacovigilance E2A: Clinical Safety Data Management: Definitions and…
In order to identify potential dangers including carcinogenicity, genotoxicity, and reprotoxicity, ICH has created a thorough set of safety guidelines. A non-clinical testing approach for determining the QT interval prolongation liability—the leading factor in drug withdrawals in recent years—has made…
The performance of stability studies, establishing appropriate thresholds for impurity testing, and a more sensible approach to pharmaceutical quality based on Good Manufacturing Practice (GMP) risk assessment are all significant milestones in the harmonisation of the Quality domain. Q1A-Q1F: Stability…
ICH, or the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, is what the acronym stands for. ICH is a collaborative effort in which regulators from Europe, Japan, and the United States participate in…
Welcome to Pharmacy India, your dedicated partner in pharmaceutical education! 🌟 Propel your exam readiness with our meticulously crafted Subject-wise Model Papers designed specifically for D. Pharma 2nd Year. Dive into a comprehensive array of insights, intricately tailored to each subject, ensuring a focused and strategic approach to your academic success.
Model Paper-1 Model Paper-2 Model Paper-3

